SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-058970
Filing Date
2020-12-31
Accepted
2020-12-31 16:21:35
Documents
15
Period of Report
2020-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20201231.htm   iXBRL 8-K 38874
2 EX-3.1 acor-ex31_24.htm EX-3.1 11746
3 EX-99.1 acor-ex991_25.htm EX-99.1 12826
4 GRAPHIC gorv5dqdodcj000001.jpg GRAPHIC 4515
  Complete submission text file 0001564590-20-058970.txt   204322

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acor-20201231.xsd EX-101.SCH 5768
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20201231_lab.xml EX-101.LAB 18732
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20201231_pre.xml EX-101.PRE 11167
8 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20201231_htm.xml XML 3419
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 201429064
SIC: 2836 Biological Products, (No Diagnostic Substances)